Psychemedics Corp
NASDAQ:PMD

Watchlist Manager
Psychemedics Corp Logo
Psychemedics Corp
NASDAQ:PMD
Watchlist
Price: 2.67 USD -1.84% Market Closed
Market Cap: $15.7m

Psychemedics Corp
Selling, General & Administrative

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Psychemedics Corp
Selling, General & Administrative Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Selling, General & Administrative CAGR 3Y CAGR 5Y CAGR 10Y
Psychemedics Corp
NASDAQ:PMD
Selling, General & Administrative
-$9.8m
CAGR 3-Years
-6%
CAGR 5-Years
2%
CAGR 10-Years
-1%
Quest Diagnostics Inc
NYSE:DGX
Selling, General & Administrative
-$2B
CAGR 3-Years
-2%
CAGR 5-Years
-4%
CAGR 10-Years
-1%
CVS Health Corp
NYSE:CVS
Selling, General & Administrative
-$970m
CAGR 3-Years
-9%
CAGR 5-Years
-16%
CAGR 10-Years
25%
Cigna Corp
NYSE:CI
Selling, General & Administrative
-$13.6B
CAGR 3-Years
-2%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
Laboratory Corporation of America Holdings
NYSE:LH
Selling, General & Administrative
-$2.2B
CAGR 3-Years
-8%
CAGR 5-Years
-6%
CAGR 10-Years
-3%
Guardant Health Inc
NASDAQ:GH
Selling, General & Administrative
-$706.1m
CAGR 3-Years
-15%
CAGR 5-Years
-19%
CAGR 10-Years
N/A
No Stocks Found

Psychemedics Corp
Glance View

Market Cap
15.7m USD
Industry
Health Care

Psychemedics Corp. engages in the provision of drug testing services through the analysis of hair samples. The company is headquartered in Acton, Massachusetts and currently employs 139 full-time employees. The firm provides testing services for the detection of drugs of abuse through the analysis of hair samples. The Company’s testing methods utilize a patented technology that digests the hair and releases drugs trapped in the hair without destroying the drugs. The firm customize its enzyme immunoassay (EIA) procedures to drug test hair samples. The firm provides screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, phenylcyclohexyl piperidine (PCP), amphetamines, opiates, synthetic cannabinoids, benzodiazepines, nicotine and fentanyl. The firm markets its corporate drug testing services through its own sales force, distributors and webinars. The firm markets its home drug testing service, PDT-90, through the Internet.

PMD Intrinsic Value
4.21 USD
Undervaluation 37%
Intrinsic Value
Price $2.67

See Also

What is Psychemedics Corp's Selling, General & Administrative?
Selling, General & Administrative
-9.8m USD

Based on the financial report for Sep 30, 2024, Psychemedics Corp's Selling, General & Administrative amounts to -9.8m USD.

What is Psychemedics Corp's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 10Y
-1%

Over the last year, the Selling, General & Administrative growth was 0%. The average annual Selling, General & Administrative growth rates for Psychemedics Corp have been -6% over the past three years , 2% over the past five years , and -1% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett